Xiling Yuan
About Xiling Yuan
Xiling Yuan is a Principal Scientist at Bristol-Myers Squibb specializing in Clinical Biomarker Immunoassays and Mass Spectrometry with extensive experience in drug discovery and development.
Current Role at Bristol-Myers Squibb
Xiling Yuan serves as a Principal Scientist, Clinical Biomarker Immunoassays & Mass Spec at Bristol-Myers Squibb in Rahway, NJ. In this role, Yuan functions as a biomarker representative and technical lead, leveraging extensive experience in bioanalysis and other specialized techniques to support drug development. Yuan collaborates with key stakeholders to provide comprehensive bioanalytical support for regulatory submissions, ensuring the precision and reliability of clinical biomarker data.
Previous Positions and Experience
Xiling Yuan has accumulated diverse experience in the pharmaceutical and research industries. Prior to joining Bristol-Myers Squibb, Yuan worked as an Associate Research Scientist at PPD from 2012 to 2013, and as a Research Scientist at Aerotek in 2012. Yuan also gained significant experience at Merck, serving as a Senior Scientist for Metabolic Disorders – Diabetes from 1996 to 2011. Earlier in their career, Yuan worked as a Research Associate in the Advanced Center for Genome Technology at the University of Oklahoma from 1995 to 1996.
Educational Background
Xiling Yuan holds an M.S. in Biochemistry from the University of Oklahoma, obtained between 1993 and 1995. Prior to this, Yuan earned a B.S. in Chemistry from Sichuan University, where studies were completed from 1985 to 1989. This strong academic foundation provided the basis for Yuan’s extensive career in biochemistry and clinical biomarker sciences.
Expertise and Technical Skills
Xiling Yuan possesses over a decade of experience in developing and implementing clinical biomarker assays. Yuan's expertise covers a range of vital techniques including bioanalysis (Clinical Biomarker Immunoassays), enzyme and cell-based assays, RT-PCR, and DNA sequencing. These skills are complemented by proven abilities in independently developing and executing projects, data analysis, problem-solving, and project management.
Focus on Drug Discovery and Development
Throughout their career, Xiling Yuan has consistently focused on drug discovery and development, particularly in the context of metabolic disorders and clinical biomarkers. Yuan's strong in vitro skills have been instrumental in advancing drug discovery projects and ensuring successful regulatory submissions, thereby contributing to the development of new therapeutic solutions.